When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KALA - Kala Pharma's KPI-121 successful in dry eye study; shares up 13% premarket
Kala Pharmaceuticals Inc.
Kala Pharmaceuticals (NASDAQ:KALA) is up 13% premarket on light volume in reaction to its announcement that a Phase 3 clinical trial, STRIDE 3, evaluating lead candidate KPI-121 in patients with dry eye disease.
More news on: Kala Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,